相关实验视频
Updated: Jan 18, 2026

05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
5.6K
延迟移植功能的生物标志物预测和移植后的预后
Rosamonde E Banks1, Michelle Wilson1, Matthew Welberry Smith2
1Leeds Institute for Medical Research at St James's, University of Leeds, Leeds, UK.
Kidney international reports
|January 16, 2026
概括
氨基酸酶-1 (ACY1) 和其他生物标志物显示出预测移植结果的前景. 需要进一步的研究来验证这些发现的临床应用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 生物标志物发现发现
背景情况:
- 延迟移植功能 (DGF) 和长期预后是移植的关键问题.
- 识别可靠的生物标志物用于DGF预测和患者结果对于改善移植成功率至关重要.
研究的目的:
- 评估氨基酸酶-1 (ACY1) 和其他血清生物标志物,以预测脏移植后的延迟移植功能 (DGF) 和死亡审查的移植存活率 (DCGS).
- 在发现和验证队伍中评估这些生物标志物的表现.
主要方法:
- 从接受脏移植的接受者中采集了血清样本,分两个阶段进行:发现队列 (n=237) 和验证队列 (n=319).
- 生物标志物包括ACY1,可溶性瘤亡因子受体-1 (sTNFR1) 和cystatin C (CysC) 在移植后的特定时间点进行测量.
- 统计分析,包括接收机运行特征 (ROC) 分析,用于评估DGF和DCGS的预测性能.
主要成果:
- 综合生物标记面板 (ACY1,sTNFR1,CysC) 显示,在发现阶段的DGF预测中,ROC曲线 (AUROC) 下的高面积为0.93,在验证阶段降至0.83.
- 在两个阶段,单个生物标志物sTNFR1,CysC和血清肌素 (Cr) 与DCGS显著相关.
- ACY1和CysC在经历DGF的已故捐赠脏移植 (DDKTs) 中显示出与DCGS的一致关联.
结论:
- 一些生物标志物,包括ACY1,sTNFR1和CysC,显示出预测DGF和移植结果的潜力.
- 需要进一步的研究和验证,以将这些生物标志物纳入临床实践,以改善移植管理.
相关概念视频
Kidney Transplant I: Introduction
345
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
345
Kidney Transplant II: Surgical Procedure
320
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
320
Kidney Transplant III: Nursing Management
318
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
318
Acute Kidney Injury III: Clinical Manifestations
827
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
827
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
801
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
801
Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271

